Zusammenfassung
Pharmaka, die die Funktion des Herz-Kreislauf-Systems modulieren, spielen in der Anästhesie und Intensivmedizin eine wichtige Rolle, weil
-
insbesondere ältere Patienten bereits an kardiovaskulären Erkrankungen leiden,
-
einige Anästhetika Herzfunktion und Blutdruck beein-chtigen können,
-
die Aufrechterhaltung der Herzfunktion bei benmten Operationen (z. B. in der Herzchirurgie, bei ausgeprägtem Blutverlust, in der Intensivmedizin) ein essenzielles Therapieziel ist.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Literatur
Antila S, Sundberg S, Lehtonen LA (2007) Clinical pharmacology of levosimendan. Clin Pharmacokinet 46:535–552
Antoniades C, Antonopoulos AS,Tousoulis D et al. (2009) Relationship between the pharmacokinetics of levosimendan and its effects on cardiovascular system. Curr Drug Metab 200910: 95–103
Bellomo R, Chapman M, Finfer S, et al. (2000) Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial: Australia and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group. Lancet 356:2139–2143
Brodde OE, Michel MC (1999) Adrenergic and muscarinic receptors in the human heart. Pharmacol Rev 51:651–688
Bylund DB, Eikenberg DC, Hieble JP et al. (1994) International Union of Pharmacology nomenclature of adrenoceptors. Pharmacol Rev 46:121–136
Cohn JN, LevineTB, Olivari MT et al. (1984) Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N EngI J Med 311: 819–823
Dixon RA, Kobilka BK, Strader DJ et al. (1986) Cloning of the gene and cDNA for mammalian beta-adrenergic receptor and homology with rhodopsin. Nature 321:75–79
Elkayam U, Ng TMH, HatamizadehP, Janmohamed M, Mehra A (2008) Renal vasodilatory action of dopamine in patients with heart failure. Circulation 117:200
Endoh M (2008) Cardiac Ca2+signaling and Ca2+sensitizers. Circ J 72:1915–1925
Kellum JA, Decker JM (2001) Use of dopamine in acute renal failure: a meta-analysis. Crit Care Med 29:1526–1531
Marik PE (2002) Low-dose dopamine: a systematic review. Intensive Care Med 28:877–883
Münzel T, Daiber A, Mülsch A (2005) Explaining the phenomenon of nitrate tolerance. Circ Res 97:618–628
Rasmussen SG, Choi HJ, Rosenbaum DM et al. (2007) Crystal structure of the human ß2adrenergic G-protein-coupled receptor. Nature 450:383–387
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Hein, L. (2011). Kardiovaskuläre Pharmaka. In: Tonner, P.H., Hein, L. (eds) Pharmakotherapie in der Anästhesie und Intensivmedizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-79156-0_10
Download citation
DOI: https://doi.org/10.1007/978-3-540-79156-0_10
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-79155-3
Online ISBN: 978-3-540-79156-0
eBook Packages: Medicine (German Language)